Table 2 Correlation between CCR7 expression and clinicopathological characteristics of bladder cancer patients
From: miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7
Characteristics | Total | Expression of CCR7 | P value | |
|---|---|---|---|---|
High (n = 30) | Low (n = 10) | |||
Age | 0.368 | |||
≤ 60 | 22 | 18(81.8 %) | 4(18.2 %) | |
> 60 | 18 | 12(66.7 %) | 6(33.3 %) | |
Gender | 0.234 | |||
Male | 27 | 10(37 %) | 17(63 %) | |
Female | 13 | 3(23.1 %) | 10(76.9 %) | |
TNM stage | 0.011* | |||
0/I | 16 | 8(93.8 %) | 1(6.2 %) | |
II/III/IV | 24 | 15(62.5 %) | 9(37.5 %) | |
Tumor size | 0.675 | |||
< 3 cm | 15 | 8(53.3 %) | 7(46.7 %) | |
≥ 3 cm | 25 | 22(88.8 %) | 3(11.2 %) | |
Histological grade | 0.001** | |||
PUNLMP/Low-grade | 18 | 10(55.6 %) | 8(44.4 %) | |
High-grade | 22 | 20(90.9 %) | 2(9.1 %) | |
Tumor invasion depth (T) | <0.001** | |||
Tis, Ta, T1 | 17 | 10(58.8 %) | 7(41.2 %) | |
T2, T3 or above | 23 | 20(87 %) | 3(13 %) | |
Lymph node metastasis (N) | <0.001** | |||
N0 | 12 | 8(66.7 %) | 4(33.3 %) | |
N1 or above | 28 | 22(78.6 %) | 6(21.4 %) | |